Back to search

Article

Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer

2020-09-15

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>The multidrug-resistant (MDR) phenotype is usually accompanied by an abnormal expression of histone deacetylase (HDAC). Given that HDAC is vital in chromatin remodeling and epigenetics, inhibiting the role of HDAC has become an important approach for tumor treatment. However, the effect of HDAC inhibitors on MDR breast cancer has not been elucidated. This study...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
334804dc-edd9-59ae-9331-7b7d767b6c71
DOI
10.21203/rs.3.rs-67615/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancerDOI 10.21203/rs.3.rs-67615/v2
Select a neighboring publication to make it the new centre.